• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行检测时间——对印度来说是危机还是伪装的机会?

COVID 19 pandemic testing time - Crisis or opportunity in disguise for India?

机构信息

Division of Molecular Pathology, Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

Division of Molecular Pathology, Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

出版信息

Semin Oncol. 2021 Apr;48(2):152-155. doi: 10.1053/j.seminoncol.2020.12.001. Epub 2021 Jan 4.

DOI:10.1053/j.seminoncol.2020.12.001
PMID:33468332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832012/
Abstract

The current SARS-CoV-2 infection or the COVID 19 pandemic has taken the world by storm, where the best health care systems in the world seem to be overwhelmed and still this virus is eluding us as we are compelled to explore the preventive and/or therapeutic interventions to control the disease outbreak as well as to prevent deaths. In parallel to clinical services, laboratories have been overwhelmed with task of keeping up with ever increasing demand for testing. Real time PCR detection of COVID19 is the gold standard method, however, has certain shortcomings in terms of availability of infrastructure, reagents, consumables, and technical expertise. All these have paved the way for the alternative testing algorithms and strategies. Countries like United States and Italy have struggled with these issues. India has been criticized for not testing enough and not adopting the right policy, but has been managing the disease within its resource limited health care system to a fair extent. The present review provides the Indian perspective of COVID 19 testing, the journey from not testing enough in the past to a vast expanse and depth of testing in present time.

摘要

当前的 SARS-CoV-2 感染或 COVID-19 大流行已经席卷全球,世界上最好的医疗保健系统似乎已经不堪重负,而我们仍然无法控制这种病毒,因为我们被迫探索预防和/或治疗干预措施来控制疾病爆发以及预防死亡。除了临床服务之外,实验室还面临着满足不断增加的检测需求的艰巨任务。实时 PCR 检测是 COVID-19 的金标准方法,但在基础设施、试剂、耗材和技术专业知识的可用性方面存在某些缺点。所有这些都为替代检测算法和策略铺平了道路。美国和意大利等国家在这些问题上苦苦挣扎。印度因检测不足和未采取正确政策而受到批评,但在资源有限的医疗保健系统内对该疾病进行了一定程度的管理。本综述提供了 COVID-19 检测的印度视角,从过去检测不足到现在广泛而深入的检测的历程。

相似文献

1
COVID 19 pandemic testing time - Crisis or opportunity in disguise for India?COVID-19 大流行检测时间——对印度来说是危机还是伪装的机会?
Semin Oncol. 2021 Apr;48(2):152-155. doi: 10.1053/j.seminoncol.2020.12.001. Epub 2021 Jan 4.
2
External quality assessment of COVID-19 real time reverse transcription PCR laboratories in India.印度新冠病毒实时逆转录聚合酶链反应实验室的外部质量评估。
PLoS One. 2022 Feb 8;17(2):e0263736. doi: 10.1371/journal.pone.0263736. eCollection 2022.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的快速诊断:即时检测及疫情期间的经验教训
Bioanalysis. 2021 Aug;13(15):1165-1167. doi: 10.4155/bio-2021-0100. Epub 2021 Jul 21.
5
Rapid COVID-19 testing: Speed, quality and cost. Can you have all three?快速 COVID-19 检测:速度、质量和成本。你能同时拥有这三者吗?
Clin Biochem. 2021 Sep;95:13-14. doi: 10.1016/j.clinbiochem.2021.05.009. Epub 2021 May 26.
6
Rapid coronavirus tests: a guide for the perplexed.快速冠状病毒检测:给困惑者的指南。
Nature. 2021 Feb;590(7845):202-205. doi: 10.1038/d41586-021-00332-4.
7
Quality assurance of SARS-CoV-2 testing laboratories during the pandemic period in India - An experience from a designated provider laboratory.印度大流行期间的 SARS-CoV-2 检测实验室的质量保证-来自指定检测机构实验室的经验。
Indian J Med Microbiol. 2024 May-Jun;49:100577. doi: 10.1016/j.ijmmb.2024.100577. Epub 2024 Apr 13.
8
[The pitfalls of preventive testing for SARS-CoV-2].[新型冠状病毒2019(SARS-CoV-2)预防性检测的陷阱]
Ned Tijdschr Geneeskd. 2020 Dec 15;165:D5622.
9
Establishing diagnostic algorithms for SARS-CoV-2 nucleic acid testing in clinical practice.建立临床实践中 SARS-CoV-2 核酸检测的诊断算法。
J Chin Med Assoc. 2021 Dec 1;84(12):1120-1125. doi: 10.1097/JCMA.0000000000000456.
10
Recent biotechnological tools for diagnosis of corona virus disease: A review.近期用于冠状病毒病诊断的生物技术工具:综述。
Biotechnol Prog. 2021 Jan;37(1):e3078. doi: 10.1002/btpr.3078. Epub 2020 Sep 21.

引用本文的文献

1
A Comparative Study of Deaths Due to the COVID-19 Pandemic During the First and Second Waves in a Tertiary Care Center of a Rural Area in South India.印度南部农村地区一家三级医疗中心新冠疫情第一波和第二波期间死亡情况的比较研究
Cureus. 2024 Jan 12;16(1):e52184. doi: 10.7759/cureus.52184. eCollection 2024 Jan.
2
Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2.基于胍的新冠病毒灭活转运培养基用于保存严重急性呼吸综合征冠状病毒2的评估及临床验证
Adv Pharmacol Pharm Sci. 2022 Jul 21;2022:1677621. doi: 10.1155/2022/1677621. eCollection 2022.
3
Incidence of SARS-CoV-2 infection among asymptomatic patients undergoing preoperative COVID testing prior to cancer surgery: ASPECT study.无症状患者在癌症手术前进行 COVID 检测时 SARS-CoV-2 感染的发生率:ASPECT 研究。
J Surg Oncol. 2022 Mar;125(4):564-569. doi: 10.1002/jso.26753. Epub 2021 Nov 16.

本文引用的文献

1
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.新型冠状病毒 SARS-CoV-2 实验室诊断面临的挑战。
Viruses. 2020 May 26;12(6):582. doi: 10.3390/v12060582.
2
Towards effective diagnostic assays for COVID-19: a review.迈向 COVID-19 有效诊断检测方法:综述。
J Clin Pathol. 2020 Jul;73(7):370-377. doi: 10.1136/jclinpath-2020-206685. Epub 2020 May 13.
3
Strategic planning to augment the testing capacity for COVID-19 in India.为增强印度 COVID-19 检测能力进行战略规划。
Indian J Med Res. 2020;151(2 & 3):210-215. doi: 10.4103/ijmr.IJMR_1166_20.
4
Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detection.克服广泛检测的瓶颈:对 COVID-19 检测的核酸检测方法的快速综述。
RNA. 2020 Jul;26(7):771-783. doi: 10.1261/rna.076232.120. Epub 2020 May 1.
5
Diagnostic performance of COVID-19 serology assays.新型冠状病毒肺炎血清学检测的诊断性能
Malays J Pathol. 2020 Apr;42(1):13-21.
6
India under COVID-19 lockdown.处于新冠疫情封锁下的印度。
Lancet. 2020 Apr 25;395(10233):1315. doi: 10.1016/S0140-6736(20)30938-7.
7
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review.严重急性呼吸综合征相关冠状病毒 2 的诊断检测:叙述性综述。
Ann Intern Med. 2020 Jun 2;172(11):726-734. doi: 10.7326/M20-1301. Epub 2020 Apr 13.
8
Covid-19: testing times.新冠疫情:考验时刻。
BMJ. 2020 Apr 8;369:m1403. doi: 10.1136/bmj.m1403.
9
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.印度针对 SARS-CoV-2 检测的实验室准备:利用病毒研究和诊断实验室网络。
Indian J Med Res. 2020;151(2 & 3):216-225. doi: 10.4103/ijmr.IJMR_594_20.
10
Diagnosing COVID-19: The Disease and Tools for Detection.诊断 COVID-19:疾病与检测工具。
ACS Nano. 2020 Apr 28;14(4):3822-3835. doi: 10.1021/acsnano.0c02624. Epub 2020 Mar 30.